High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study

Descripción del Articulo

This work was mainly supported by the Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC-Peru) / Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT, Convenio 175–2015). The work from BBA was supported by intramural research program from...

Descripción completa

Detalles Bibliográficos
Autores: Calderon R.I., Arriaga M.B., Lopez K., Barreda N.N., Sanabria O.M., Fróes Neto J.F., Araújo D.N., Lecca L., Andrade B.B.
Formato: artículo
Fecha de Publicación:2019
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/2299
Enlace del recurso:https://hdl.handle.net/20.500.12390/2299
https://doi.org/10.1186/s12879-019-4416-2
Nivel de acceso:acceso abierto
Materia:Tuberculosis
Comorbidity
Diabetes mellitus
Prediabetes
Prevalence
http://purl.org/pe-repo/ocde/ford#3.02.27
id CONC_8323a4f091c2610c5bc69b19bc8868c0
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/2299
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
title High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
spellingShingle High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
Calderon R.I.
Tuberculosis
Comorbidity
Diabetes mellitus
Prediabetes
Prevalence
http://purl.org/pe-repo/ocde/ford#3.02.27
title_short High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
title_full High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
title_fullStr High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
title_full_unstemmed High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
title_sort High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study
author Calderon R.I.
author_facet Calderon R.I.
Arriaga M.B.
Lopez K.
Barreda N.N.
Sanabria O.M.
Fróes Neto J.F.
Araújo D.N.
Lecca L.
Andrade B.B.
author_role author
author2 Arriaga M.B.
Lopez K.
Barreda N.N.
Sanabria O.M.
Fróes Neto J.F.
Araújo D.N.
Lecca L.
Andrade B.B.
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Calderon R.I.
Arriaga M.B.
Lopez K.
Barreda N.N.
Sanabria O.M.
Fróes Neto J.F.
Araújo D.N.
Lecca L.
Andrade B.B.
dc.subject.none.fl_str_mv Tuberculosis
topic Tuberculosis
Comorbidity
Diabetes mellitus
Prediabetes
Prevalence
http://purl.org/pe-repo/ocde/ford#3.02.27
dc.subject.es_PE.fl_str_mv Comorbidity
Diabetes mellitus
Prediabetes
Prevalence
dc.subject.ocde.none.fl_str_mv http://purl.org/pe-repo/ocde/ford#3.02.27
description This work was mainly supported by the Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC-Peru) / Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT, Convenio 175–2015). The work from BBA was supported by intramural research program from FIOCRUZ, by the National Institutes of Health (U01AI115940 and U01AI069923) and by the Departamento de Ciência e Tecnologia (DECIT) - Secretaria de Ciência e Tecnologia (SCTIE) – Ministério da Saúde (MS), Brazil (25029.000507/2013–07). MBA receives a fellowship from the Fundaçăo de Amparo à Pesquisa da Bahia (FAPESB). BBA is a senior scientist from the Conselho Nacional de Desenvolvimento Científico e Tecnológico. The funders had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
publishDate 2019
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/2299
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1186/s12879-019-4416-2
dc.identifier.scopus.none.fl_str_mv 2-s2.0-85072099319
url https://hdl.handle.net/20.500.12390/2299
https://doi.org/10.1186/s12879-019-4416-2
identifier_str_mv 2-s2.0-85072099319
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv BMC Infectious Diseases
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.publisher.none.fl_str_mv BioMed Central Ltd.
publisher.none.fl_str_mv BioMed Central Ltd.
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1839175514696187904
spelling Publicationrp05447600rp05443600rp05444600rp05446600rp05442600rp05449600rp05450600rp05445600rp05448600Calderon R.I.Arriaga M.B.Lopez K.Barreda N.N.Sanabria O.M.Fróes Neto J.F.Araújo D.N.Lecca L.Andrade B.B.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2019https://hdl.handle.net/20.500.12390/2299https://doi.org/10.1186/s12879-019-4416-22-s2.0-85072099319This work was mainly supported by the Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC-Peru) / Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT, Convenio 175–2015). The work from BBA was supported by intramural research program from FIOCRUZ, by the National Institutes of Health (U01AI115940 and U01AI069923) and by the Departamento de Ciência e Tecnologia (DECIT) - Secretaria de Ciência e Tecnologia (SCTIE) – Ministério da Saúde (MS), Brazil (25029.000507/2013–07). MBA receives a fellowship from the Fundaçăo de Amparo à Pesquisa da Bahia (FAPESB). BBA is a senior scientist from the Conselho Nacional de Desenvolvimento Científico e Tecnológico. The funders had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.Background: The accuracy of different laboratory tests for diagnosis of diabetes mellitus (DM) and prediabetes (preDM) in populations exposed to tuberculosis (TB) remains poorly understood. Here, we examined the prevalence of DM and preDM in TB affected people in Lima, Peru. Methods: A prospective cohort study of patients affected TB and their household contacts (HHC), was conducted between February and November 2017 in Lima, Peru. Fasting plasma glucose (FPG), HbA1c and oral glucose tolerance test (OGTT) were used to detect DM and preDM in a prospective cohort of TB patients (n = 136) and household contacts (n = 138). Diagnostic performance of the laboratory tests was analyzed. Potential effects of sociodemographic and clinical factors on detection of dysglycemia were analyzed. Results: In TB patients, prevalence of DM and preDM was 13.97 and 30.88% respectively. Lower prevalence of both DM (6.52%) and preDM (28.99%) were observed in contacts. FPG, HbA1c and OGTT had poor agreement in detection of preDM in either TB cases or contacts. TB-DM patients had substantially lower hemoglobin levels, which resulted in low accuracy of HbA1c-based diagnosis. Classic sociodemographic and clinical characteristics were not different between TB patients with or without dysglycemia. Conclusion: High prevalence of DM and preDM was found in both TB patients and contacts in Lima. Anemia was strongly associated with TB-DM, which directly affected the diagnostic performance of HbA1c in such population. © 2019 The Author(s).Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengBioMed Central Ltd.BMC Infectious Diseasesinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/4.0/TuberculosisComorbidity-1Diabetes mellitus-1Prediabetes-1Prevalence-1http://purl.org/pe-repo/ocde/ford#3.02.27-1High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort studyinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC20.500.12390/2299oai:repositorio.concytec.gob.pe:20.500.12390/22992024-05-30 16:07:00.4https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_14cbinfo:eu-repo/semantics/closedAccessmetadata only accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="4207df89-e362-466e-9420-a5af96ba1399"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: A prospective cohort study</Title> <PublishedIn> <Publication> <Title>BMC Infectious Diseases</Title> </Publication> </PublishedIn> <PublicationDate>2019</PublicationDate> <DOI>https://doi.org/10.1186/s12879-019-4416-2</DOI> <SCP-Number>2-s2.0-85072099319</SCP-Number> <Authors> <Author> <DisplayName>Calderon R.I.</DisplayName> <Person id="rp05447" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Arriaga M.B.</DisplayName> <Person id="rp05443" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Lopez K.</DisplayName> <Person id="rp05444" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Barreda N.N.</DisplayName> <Person id="rp05446" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Sanabria O.M.</DisplayName> <Person id="rp05442" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Fróes Neto J.F.</DisplayName> <Person id="rp05449" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Araújo D.N.</DisplayName> <Person id="rp05450" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Lecca L.</DisplayName> <Person id="rp05445" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Andrade B.B.</DisplayName> <Person id="rp05448" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>BioMed Central Ltd.</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc-nd/4.0/</License> <Keyword>Tuberculosis</Keyword> <Keyword>Comorbidity</Keyword> <Keyword>Diabetes mellitus</Keyword> <Keyword>Prediabetes</Keyword> <Keyword>Prevalence</Keyword> <Abstract>Background: The accuracy of different laboratory tests for diagnosis of diabetes mellitus (DM) and prediabetes (preDM) in populations exposed to tuberculosis (TB) remains poorly understood. Here, we examined the prevalence of DM and preDM in TB affected people in Lima, Peru. Methods: A prospective cohort study of patients affected TB and their household contacts (HHC), was conducted between February and November 2017 in Lima, Peru. Fasting plasma glucose (FPG), HbA1c and oral glucose tolerance test (OGTT) were used to detect DM and preDM in a prospective cohort of TB patients (n = 136) and household contacts (n = 138). Diagnostic performance of the laboratory tests was analyzed. Potential effects of sociodemographic and clinical factors on detection of dysglycemia were analyzed. Results: In TB patients, prevalence of DM and preDM was 13.97 and 30.88% respectively. Lower prevalence of both DM (6.52%) and preDM (28.99%) were observed in contacts. FPG, HbA1c and OGTT had poor agreement in detection of preDM in either TB cases or contacts. TB-DM patients had substantially lower hemoglobin levels, which resulted in low accuracy of HbA1c-based diagnosis. Classic sociodemographic and clinical characteristics were not different between TB patients with or without dysglycemia. Conclusion: High prevalence of DM and preDM was found in both TB patients and contacts in Lima. Anemia was strongly associated with TB-DM, which directly affected the diagnostic performance of HbA1c in such population. © 2019 The Author(s).</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.439043
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).